This trial demonstrates that the selective serotonin reuptake inhibitor citalopram offers an advantageous new treatment of poststroke depression that is both safe and effective.
No takes yet. Share an insight, caveat, or question.
Andersen et al. (1994) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: